课题基金 / 基金详情

Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability

Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability
鉴定用于开发口服益生菌的菌株,旨在提高一氧化氮的生物利用度
批准号:
10666185
负责人:
DANIEL B KIM-SHAPIRO
金额:
$19.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2025-05-31

项目摘要

项目成果

DANIEL B KIM-SHAPIRO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nitric oxide (NO) plays critical roles in a myriad of cellular and molecular mechanisms regulating physiology and function of various organs and systems. Depletion of NO and its reduced bioavailability contributes to the pathology of several human diseases including anemia, malaria, heart failure, obesity, diabetes and neurodegeneration. Recent reports suggest that oral microbiota regulate NO homeostasis through the action of some bacteria that have the ability to perform reduction of the nutrient anion nitrate to nitrite and NO. Several clinical trials have taken advantage of this nitrate-nitrite-NO cycle employing oral nitrate to deliver NO. However, many individuals do not respond to oral nitrate, and we hypothesize that this is due to a deficiency in nitrate to nitrite converting bacteria. Hence, developing microbiome modulators like probiotics to enhance and/or perform increased nitrate reduction and NO formation can potentially serve as a solution to recover diminished NO levels and bioavailability. The goal of this project is to test the role of oral bacteria in determining the extent of conversion of oral nitrate to plasma nitrite while developing novel human-origin probiotics of nitrate-nitrite-NO formation abilities and determine their adherence potential to colonize and form biofilms in epithelia. In Aim 1 we will use novel, high throughput screening assays to identify candidate bacterial strains with efficient nitrate to nitrite conversion abilities obtained from the oral cavity and characterize these strains. In Aim 2 we will determine the oral cavity colonizing capabilities of the nitrate to nitrite converting bacterial strains. In Aim 3, we will test the role of these bacterial strains’ in determining the extent of conversion of oral nitrate to plasma nitrite in a murine model. Successful completion of these studies could lead to probiotics against human diseases caused by NO homeostasis abrogation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitric Oxide Donor Compounds for the Treatment of Hemolytic Conditions
  • 批准号:
    7387531
  • 项目类别:
  • 资助金额:
    $16.16万
  • 财政年份:
    2008
  • 负责人:
    DANIEL B KIM-SHAPIRO
  • 依托单位:
Nitric Oxide Donor Compounds for the Treatment of Hemolytic Conditions
  • 批准号:
    7554123
  • 项目类别:
  • 资助金额:
    $16.27万
  • 财政年份:
    2008
  • 负责人:
    DANIEL B KIM-SHAPIRO
  • 依托单位:
Nitrite and Nitric Oxide in Sickle Cell Blood
  • 批准号:
    7166100
  • 项目类别:
  • 资助金额:
    $10.37万
  • 财政年份:
    2004
  • 负责人:
    DANIEL B KIM-SHAPIRO
  • 依托单位:
Nitrite and Nitric Oxide in Sickle Cell Blood
  • 批准号:
    6848917
  • 项目类别:
  • 资助金额:
    $10.37万
  • 财政年份:
    2004
  • 负责人:
    DANIEL B KIM-SHAPIRO
  • 依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    熊泽康
  • 依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2021
  • 负责人:
    陈英伟
  • 依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    孙伟力
  • 依托单位: